Genetic Signatures has ended proposed merger with Microba Life Sciences
(Image source: Canva)
Get your Free Report on Top 5 ASX stocks for 2025
Genetic Signatures Limited (ASX: GSS) announced on 18 November 2026 that it will not proceed with the proposed merger with Microba Life Sciences Limited because of concerns about Microba’s ability to fund the transaction. The decision came after several months of discussions and due diligence between the two companies.
Microba informed the market that it does not have the financial capacity to complete the proposed merger without raising additional capital.
GSS had considered providing unsecured debt funding to meet Microba’s working capital needs during the merger process but its board decided against this option because of the associated risks and potential regulatory requirements. GSS has decided not to pursue the proposed merger which brings discussions between the two companies to an end.
The company will make a separate announcement about the formal withdrawal of Resolution 4 from the agenda of its annual general meeting which is scheduled for 30 November 2026.
GSS will also provide a further market update on the impact of the decision and the withdrawal of Resolution 4 on the Takeovers Panel application lodged by BCAL Diagnostics Limited on 13 November 2026.
(Source:- Company Announcements)
Disclaimer
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.
Feature News
Checkout Our Recommendation for free - 7 days free trial
Start Free TrialRecent News
Perenti Secures A$1 Billion Five-Year Underground ..
ClearVue secures award for a public project in Sin..
Omega Oil & Gas Records Queensland’s Deepest Wel..
Talga's natural graphite anode has achieved 5x lon..
Alfabs has acquired J&J Vac pump business to unloc..